ampicillin has been researched along with beta-alanine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Abe, T; Fukuoka, T; Inoue, H; Ohya, S | 1 |
Fukuda, T; Furuta, Y; Minami, S; Mitsuyama, J; Nakata, M; Nomura, N; Takahata, M; Yamada, H | 1 |
Ameshima, S; Demura, Y; Ishizaki, T; Kadowaki, M; Miyamori, I; Mizuno, S; Uesaka, D | 1 |
Cheng, HT; Cheng, JW; Chih, YH; Chu, HL; Liang, CW; Yip, BS; Yu, HY | 1 |
1 trial(s) available for ampicillin and beta-alanine
Article | Year |
---|---|
Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Alanine; Clindamycin; Female; Humans; Injections, Intravenous; Male; Pneumonia, Aspiration; Prospective Studies; Severity of Illness Index; Sulbactam; Thienamycins | 2005 |
4 other study(ies) available for ampicillin and beta-alanine
Article | Year |
---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2001 |
[In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
Topics: 4-Quinolones; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; beta-Alanine; Ceftazidime; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infusions, Intravenous; Male; Meropenem; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazines; Rats; Thienamycins; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2002 |
Boosting salt resistance of short antimicrobial peptides.
Topics: Amino Acid Sequence; Ampicillin; Anti-Infective Agents; beta-Alanine; Drug Stability; Erythrocytes; Escherichia coli; Hemolysis; Humans; Microbial Sensitivity Tests; Peptides; Serum; Sodium Chloride; Tryptophan | 2013 |